On 21 August 2019, orphan designation EU/3/19/2193 was granted by the European Commission to Laboratorios Tillomed Spain, S.L.U, Spain, for acetazolamide for the treatment of periodic paralysis.
|Disease / condition||
Treatment of periodic paralysis
|Date of first decision||
|EU designation number||
Review of designation
Sponsor's contact details
For contact details of patients’ organisations whose activities are targeted at rare diseases, see: